Janux Therapeutics (JANX) EPS (Basic) (2020 - 2026)
Janux Therapeutics' (JANX) quarterly EPS (Basic) came in at -$0.84 in Q1 2026, up 66.3% year-on-year from -$0.51 in Q1 2025, and down 63.62% on a QoQ basis from -$0.52 in Q4 2025.
Janux Therapeutics (JANX) EPS (Basic) (2020 - 2026) Analysis & Trends
Janux Therapeutics (JANX) has 7 years of EPS (Basic) data on file, last reported at -$0.84 in Q1 2026.
- On a quarterly basis, EPS (Basic) rose 66.3% year-over-year to -$0.84 in Q1 2026; TTM through Mar 2026 was -$5.56, a 57.54% increase from a year earlier, with the FY2025 full-year figure at -$2.31, up 71.15% from the prior year.
- EPS (Basic) for Q1 2026 stood at -$0.84, down from -$0.52 in the prior quarter.
- Over the last five years, EPS (Basic) for JANX reached as high as -$0.27 in Q4 2023 and fell as low as -$6.25 in Q3 2024.
- Historically, EPS (Basic) has averaged -$1.96 across 5 years, with a median of -$1.31 in 2022.
- Across the five-year window, EPS (Basic) plunged 972.57% in 2024 and soared 66.3% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$0.4 in 2022, then jumped by 32.49% to -$0.27 in 2023, then sank by 40.79% to -$0.38 in 2024, then plunged by 37.07% to -$0.52 in 2025, then slumped by 63.62% to -$0.84 in 2026.
- Per Business Quant data, the three most recent EPS (Basic) figures were -$0.84 in Q1 2026, -$0.52 in Q4 2025, and -$2.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Janux Therapeutics | 964.43 Mn | 964.43 Mn | - | -0.84 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.84 |
| Dec 31, 2025 | -0.52 |
| Sep 30, 2025 | -2.11 |
| Jun 30, 2025 | -2.14 |
| Mar 31, 2025 | -2.50 |
| Dec 31, 2024 | -0.38 |
| Sep 30, 2024 | -6.25 |
| Jun 30, 2024 | -5.38 |
| Mar 31, 2024 | -5.47 |
| Dec 31, 2023 | -0.27 |
| Sep 30, 2023 | -0.58 |
| Jun 30, 2023 | -1.29 |
| Mar 31, 2023 | -1.31 |
| Dec 31, 2022 | -0.40 |
| Sep 30, 2022 | -1.31 |
| Jun 30, 2022 | -1.32 |
| Mar 31, 2022 | -1.17 |
| Dec 31, 2021 | -0.57 |
| Sep 30, 2021 | -2.03 |
| Jun 30, 2021 | -0.62 |